127 related articles for article (PubMed ID: 10228850)
1. Clinical and biological features of t1 ductal adenocarcinoma of the pancreas.
Takao S; Shinchi H; Sha K; Natsugoe S; Maenohara S; Suenaga T; Nishimata Y; Aikou T
Hepatogastroenterology; 1999; 46(25):498-503. PubMed ID: 10228850
[TBL] [Abstract][Full Text] [Related]
2. Nodal involvement is strongest predictor of poor survival in patients with invasive adenocarcinoma of the head of the pancreas.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
Hepatogastroenterology; 2006; 53(69):447-51. PubMed ID: 16795990
[TBL] [Abstract][Full Text] [Related]
3. p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy.
Kawahira H; Kobayashi S; Kaneko K; Asano T; Ochiai T
Hepatogastroenterology; 2000; 47(34):973-7. PubMed ID: 11020860
[TBL] [Abstract][Full Text] [Related]
4. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
[TBL] [Abstract][Full Text] [Related]
5. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP
Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671
[TBL] [Abstract][Full Text] [Related]
6. Expression of thymidine phosphorylase is associated with a poor prognosis in patients with ductal adenocarcinoma of the pancreas.
Takao S; Takebayashi Y; Che X; Shinchi H; Natsugoe S; Miyadera K; Yamada Y; Akiyama S; Aikou T
Clin Cancer Res; 1998 Jul; 4(7):1619-24. PubMed ID: 9676835
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival after surgical resection for pancreatic cancer.
Yoshizawa K; Nagai H; Kurihara K; Sata N; Kawai T; Saito K
Hepatogastroenterology; 2001; 48(40):1153-6. PubMed ID: 11490822
[TBL] [Abstract][Full Text] [Related]
8. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of combined pancreas and portal vein resection in surgery for pancreatic adenocarcinoma.
Aramaki M; Matsumoto T; Etoh T; Ishio T; Himeno Y; Sasaki A; Yada K; Kawano K; Kitano S
Hepatogastroenterology; 2003; 50(49):263-6. PubMed ID: 12630036
[TBL] [Abstract][Full Text] [Related]
10. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
[TBL] [Abstract][Full Text] [Related]
11. Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.
Skalicky DA; Kench JG; Segara D; Coleman MJ; Sutherland RL; Henshall SM; Musgrove EA; Biankin AV
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1941-7. PubMed ID: 17035403
[TBL] [Abstract][Full Text] [Related]
12. Long-term survivors after resection of carcinoma of the head of the pancreas: significance of histologically curative resection.
Nagakawa T; Sanada H; Inagaki M; Sugama J; Ueno K; Konishi I; Ohta T; Kayahara M; Kitagawa H
J Hepatobiliary Pancreat Surg; 2004; 11(6):402-8. PubMed ID: 15619016
[TBL] [Abstract][Full Text] [Related]
13. Analysis of long-term survivors after surgical resection for pancreatic cancer.
Han SS; Jang JY; Kim SW; Kim WH; Lee KU; Park YH
Pancreas; 2006 Apr; 32(3):271-5. PubMed ID: 16628082
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors for long-term survival in patients with pancreatic carcinoma.
Takahashi T; Niino N; Ishikura H; Okushiba S; Dohke M; Katoh H
Hepatogastroenterology; 1997; 44(17):1463-8. PubMed ID: 9356873
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of angiogenesis and its correlations with thymidine phosphorylase and p53 expression in ductal adenocarcinoma of the pancreas.
Jinfeng M; Kimura W; Sakurai F; Moriya T; Mizutani M; Hirai I
Hepatogastroenterology; 2007 Sep; 54(78):1635-40. PubMed ID: 18019682
[TBL] [Abstract][Full Text] [Related]
16. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Sueda T
J Surg Oncol; 2009 Jul; 100(1):13-8. PubMed ID: 19384908
[TBL] [Abstract][Full Text] [Related]
17. Surgical treatment of intraductal papillary-mucinous tumors of the pancreas.
Kanazumi N; Nakao A; Kaneko T; Takeda S; Harada A; Inoue S; Nagasaka T; Nakashima N
Hepatogastroenterology; 2001; 48(40):967-71. PubMed ID: 11490850
[TBL] [Abstract][Full Text] [Related]
18. Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases.
Zhou GW; Wu WD; Xiao WD; Li HW; Peng CH
Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):130-4. PubMed ID: 15730937
[TBL] [Abstract][Full Text] [Related]
19. Metastatic potential in T1 and T2 colorectal cancer.
Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas.
Shimamura T; Sakamoto M; Ino Y; Shimada K; Kosuge T; Sato Y; Tanaka K; Sekihara H; Hirohashi S
Clin Cancer Res; 2002 Aug; 8(8):2570-5. PubMed ID: 12171885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
